awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33890406-019F1E75-33F2-4431-ABEA-55DE6FE9CE19
Q33890406-019F1E75-33F2-4431-ABEA-55DE6FE9CE19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33890406-019F1E75-33F2-4431-ABEA-55DE6FE9CE19
Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes
P2860
Q33890406-019F1E75-33F2-4431-ABEA-55DE6FE9CE19
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33890406-019F1E75-33F2-4431-ABEA-55DE6FE9CE19
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2a3b7cda6956ceec99e737ae2191b55e4603436
P2860
Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.